Emergency physicians pride themselves on recognizing and treating life-threatening illness under pressure. Yet one of the most lethal, common, and treatable conditions presenting to our EDs still often receives fragmented, stigmatized care: substance use disorder. The opioid crisis has evolved into an era of increasingly toxic and unpredictable drug supplies, including ultra-potent synthetic opioids such as nitazenes. Between 2016 and 2021, more than 27,000 Canadians died from opioid toxicity, while opioid-related ED visits continue to rise sharply. Patients discharged with untreated opioid use disorder face mortality rates approaching 5% within 12 months. Despite this, substance use disorder is still not consistently approached with the same urgency and systems-based care as other chronic high-risk illnesses. In this episode, Dr. Bjug Borgundvaag, Tish Mizon and Kari Herbert discuss how stigma affects care in the ED and how trauma-informed communication, person-first language, compassionate care, peer navigators and Bridge-style addiction programs can improve outcomes for both patients and clinicians.

Podcast production, sound design & editing by Anton Helman

Written Summary  by Anton Helman May, 2026

Cite this podcast as: Helman, A. Herbert, K. Mizon, T. Borgundvaag, B. Episode 218 Substance Use Disorder in the ED – Stigma, Compassion and System Change. Emergency Medicine Cases. May, 2026. https://emergencymedicinecases.com/substance-use-disorder-stigma-compassion-system-change. Accessed June 10, 2026

Why Substance Use Disorder Belongs Squarely in Emergency Medicine

Substance use disorder is a chronic medical illness associated with profound morbidity and mortality, and the emergency department is often the only healthcare access point for these patients. Many patients who use drugs do not have consistent access to primary care, addiction medicine, housing supports or mental health resources. The ED therefore becomes the default healthcare system for acute illness, injury, withdrawal, overdose, pain crises and infections.

Patients with substance use disorder commonly present with:

  • Overdose
  • Withdrawal
  • Serious infections including endocarditis and abscesses
  • Trauma
  • Psychiatric crises
  • Acute and chronic pain syndromes
  • Complications related to being unhoused and poverty

One of the major themes throughout this episode is that many patients with substance use disorder present with legitimate medical emergencies that risk being missed because clinicians prematurely anchor on intoxication, drug-seeking behavior or psychiatric explanations. Medical emergencies may be missed or minimized because of assumptions surrounding their substance use history. Not every patient with substance use disorder is seeking abstinence or formal treatment. Emergency clinicians should not frame every encounter exclusively through that lens. Harm reduction, symptom management, trust-building and respectful care remain worthwhile interventions even when patients are not ready for recovery-oriented treatment.

Stigma in the ED: What Patients With Substance Use Disorder Experience

A qualitative Ontario-based research study discussed in this episode interviewed 51 people who use drugs across rural, community and academic emergency departments, as well as emergency physicians, nurses and other healthcare providers. The findings were strikingly consistent across settings.

Patients frequently described:

  • Feeling dehumanized or dismissed
  • Being assumed to be drug-seeking before assessment
  • Being physically segregated into hallways or psychiatric areas
  • Inadequate pain control
  • Delayed reassessment and treatment
  • Feeling feared rather than cared for
  • Avoiding future healthcare encounters because of prior experiences

Several patients stated they would rather risk death than return to the ED because of prior stigmatizing experiences. One of the most sobering points is that some patients perceive the hospital as more threatening than the illness itself. Patients repeatedly described not feeling believed, particularly when reporting pain. Many perceived that clinicians saw “the substance” before seeing the person. Others described hearing stigmatizing language during EMS handoff or triage conversations, which immediately shaped their expectations for the remainder of the visit.

One important concept is that stigma often begins before the physician enters the room. Language used such as: “Drug seeker”, “Frequent flyer”, “Addict”, “The overdose in bed 13”, “The one from the park” can influence diagnostic reasoning, communication style, analgesic prescribing and disposition decisions long before a proper assessment occurs.

Person-First Language and the Hidden Power of Documentation

Reducing stigma begins with language. Person-first terminology reframes the patient as a human being first rather than defining them solely by a diagnosis or behavior. Instead of: “Addict”, “Substance abuser”, “Drug user” use: “Person with substance use disorder”, “Person who uses drugs”, “Person experiencing homelessness”. Language in the medical record shapes future encounters. Once stigmatizing labels appear in prior notes, subsequent clinicians may enter the room already biased toward mistrust or suspicion. Seemingly small language choices therefore have ripple effects that influence future care, diagnostic reasoning and patient trust. Patients are acutely aware of how staff speak about them, even when conversations occur at a distance or outside the room. The language used during triage, EMS handoff and nursing discussions can immediately signal to patients whether they are entering a safe environment or a hostile one.

Geography Is Destiny: Where Patients Are Placed Matters

Patients with substance use disorder are frequently managed in hallways, waiting rooms or psychiatric holding areas, often reflexively rather than based on clinical need.Where a patient is placed often determines the care they receive. Hallway medicine increases the risk of missed reassessment, delayed recognition of deterioration and inadequate symptom management. Psychiatric holding areas may be retraumatizing for some patients and can subtly communicate that the healthcare team views the patient primarily as a behavioral problem rather than a medical patient. The key principle is that patients with substance use disorder should be placed according to their medical needs, not according to stigma or assumptions. A patient with opioid use disorder and chest pain still deserves appropriate cardiac monitoring and serial assessment. A patient with severe infection or acute pain deserves the same standard of analgesia and reassessment as any other patient.

Compassionate Care Improves Outcomes in Patients With Substance Use Disorder

This episode builds heavily on principles discussed previously in the EM Cases Episdode 145 Compassionate Care with Dr. Barbara Tatham. Compassionate care is not merely a soft skill or optional add-on to technical emergency medicine practice. There is substantial evidence that compassion improves:

  • Patient trust
  • Treatment adherence
  • Symptom control
  • PTSD outcomes
  • Healthcare utilization
  • Follow-up compliance
  • Provider wellness and burnout

Importantly, compassionate care may also protect clinicians themselves. Burnout and depersonalization are closely linked, and several studies suggest that meaningful human connection and compassionate practice may actually reduce emotional exhaustion and improve professional fulfillment. Compassionate care does not require lengthy encounters. Brief empathic statements, eye contact, validation and attentive listening can dramatically alter how patients experience their care. Many patients with substance use disorder arrive in the ED expecting hostility; even small gestures of respect and curiosity can therefore become disproportionately meaningful.

Practical Communication Strategies for Building Trust in Patients With Substance Use Disorder

It is important to ask permission before discussing substance use. Rather than launching into interrogation-style questioning, clinicians can ask:

  • “Would it be okay if I ask you about substance use?”
  • “Can we talk about that for a moment?”

This simple step restores a sense of autonomy and collaboration.

Use open-ended, motivational interviewing–style questions. Asking patients:

  • “How are you feeling about your substance use?”
  • “What concerns do you have?”
  • “What has your experience with healthcare been like?”
  • “What happened to you?”

Another important communication principle is validation. Simple statements such as:

  • “I believe you.”
  • “Thank you for telling me that.”
  • “I appreciate you trusting me with that information.”

Patients notice body language, tone, posture and eye contact just as much as the actual words being spoken.

Trauma-informed care is a central communication strategy. Many patients with substance use disorder have extensive histories of trauma, violence, homelessness or prior negative healthcare experiences. Agitation, hostility or distrust may therefore reflect fear and self-protection rather than manipulation or aggression. Reframing the encounter from “What’s wrong with you?” to “What happened to you?” fundamentally changes the tone of care.

Pain Management and the Fear of Undertreatment in Substance Use Disorder

Patients who use fentanyl or other potent opioids often have extraordinarily high opioid tolerance, creating significant challenges around analgesia and withdrawal management. Patients report being consistently undertreated for pain, and clinicians report that they are fearful of prescribing opioids or uncomfortable managing high-tolerance states.

Opioid use disorder does not invalidate pain. Clinicians must distinguish:

  • Addiction
  • Tolerance
  • Dependence
  • Acute pain management needs

Undertreated pain contributes directly to mistrust, patient-directed discharge and poor outcomes.

The Bridge Model and the Role of Peer Navigators

The California Bridge model integrates addiction medicine directly into acute care settings through:

  • ED-initiated buprenorphine
  • Peer navigators
  • Harm reduction
  • Motivational interviewing
  • Rapid outpatient linkage

Bridge programs improve treatment engagement, staff satisfaction, follow-up rates and patient experiences. One of the most powerful aspects of the model is the use of substance use navigators with lived experience who can help patients navigate the enormous logistical barriers surrounding addiction treatment.

These navigators understand the realities of:

  • Transportation barriers
  • Insurance limitations
  • Housing instability
  • Rapidly changing addiction treatment systems
  • Outpatient follow-up challenges

Patients interviewed in the Ontario study similarly emphasized wanting advocates with lived experience present within emergency departments. Peer navigators were repeatedly identified as one of the most meaningful potential system improvements.

Key Take Home Points for Substance Use Disorder Stigma, Compassion and Systems Change

  • Substance use disorder is a chronic medical illness that deserves the same seriousness and urgency as other high-risk chronic diseases seen in emergency medicine. Stigma directly worsens outcomes through delayed diagnosis, mistrust, inadequate analgesia and avoidance of future healthcare encounters.
  • Compassionate care is not time-consuming, and even brief empathic interventions can improve trust, adherence and outcomes. Person-first language matters, both at the bedside and within chart documentation. Asking “What happened to you?” instead of “What’s wrong with you?” reframes the encounter in a trauma-informed way that can fundamentally change communication and trust.
  • Patients with substance use disorder deserve appropriate analgesia, reassessment and medical care based on their presenting complaint rather than assumptions surrounding substance use. Bridge-style models and peer navigators represent promising systems-level approaches that improve outcomes for patients and clinicians alike.

Compassionate care for patients with substance use disorder is not separate from good emergency medicine — it is good emergency medicine.

Substance Use Stigma, Compassion, Systems Change on EM Cases

References

  1. Koh JJ, Klaiman M, Miles I, Punja Z, Smith PM, Dong K, Borgundvaag B, et al. Emergency department management of people with opioid use disorder: a national survey of Canadian emergency physicians. Can J Emerg Med. 2020;22(5):694-703.
  2. Borgundvaag B, Kestler A, Campbell S, et al. Substance use disorders and the emergency department: evidence-informed approaches to care and systems integration. Acad Emerg Med. 2024;31(9):1043-1051.
  3. Stewart M. Effective physician-patient communication and health outcomes: a review. CMAJ. 1995;152(9):1423-1433.
  4. Fogarty LA, Curbow BA, Wingard JR, McDonnell K, Somerfield MR. Can 40 seconds of compassion reduce patient anxiety? J Clin Oncol. 1999;17(1):371-379.
  5. Moss J, Roberts MB, Shea L, et al. Healthcare provider compassion is associated with lower PTSD symptoms among patients with life-threatening medical emergencies: a prospective cohort study. Intensive Care Med. 2019;45(6):815-822.
  6. Pereira L, Figueiredo-Braga M, Carvalho IP. Preoperative anxiety in ambulatory surgery: the impact of an empathic patient-centered approach on psychological and clinical outcomes. Patient Educ Couns. 2016;99(5):733-738.
  7. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;36(8):1138-1161.
  8. Shanafelt TD, Balch CM, Bechamps G, et al. Burnout and medical errors among American surgeons. Ann Surg. 2010;251(6):995-1000.
  9. Jeffrey D. Empathy, sympathy and compassion in healthcare: is there a problem? Is there a difference? Does it matter? J R Soc Med. 2016;109(12):446-452.
  10. Redelmeier DA, Molin JP, Tibshirani RJ. A randomised trial of compassionate care for the homeless in an emergency department. Lancet. 1995;345(8958):1131-1134.
  11. Marvel MK, Epstein RM, Flowers K, Beckman HB. Soliciting the patient’s agenda: have we improved? JAMA. 1999;281(3):283-287.
  12. Herring AA, Schultz CW, Yang E, Greenwald MK. Rapid induction onto sublingual buprenorphine after opioid overdose and successful linkage to treatment for opioid use disorder. Am J Emerg Med. 2019;37(12):2259-2262.
  13. D’Onofrio G, O’Connor PG, Pantalon MV, et al. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313(16):1636-1644.
  14. Kilaru AS, Xiong A, Lowenstein M, et al. Incidence of treatment for opioid use disorder following nonfatal overdose in commercially insured patients. JAMA Netw Open. 2020;3(5):e205852.
  15. Canadian Centre on Substance Use and Addiction. Toxic Drug Crisis in Canada. Ottawa, ON: CCSA; 2023.
  16. Substance Abuse and Mental Health Services Administration (SAMHSA). TIP 63: Medications for Opioid Use Disorder. Rockville, MD: SAMHSA; 2021.